Literature DB >> 12841402

Newborn jaundice and kernicterus--health and societal perspectives.

Vinod K Bhutani1, Lois H Johnson.   

Abstract

Kernicterus, a preventable injury to the brain from severe neonatal jaundice, has re-emerged in the United States as a public and societal health concern. Kernicterus, in its usually recognized form, causes devastating disabilities, including athetoid cerebral palsy and speech and hearing impairment. This condition not only ranks amongst the highest cost per new case (per CDCs Financial Burden of Disability study, 1992), but also results in profound and uncompromising grief for the family and loss to siblings of healthy, talkative playmates. And for the child with kernicterus (usually remarkably intelligent, but trapped in an uncontrollable body), grief and frustration are enormous. In 2001 national healthcare organizations, including Centers for Disease Control (CDC), the Joint Commission for the Accreditation of Healthcare Organizations (JACHO) and the American Academy of Pediatrics (AAP) issued alerts to all accredited hospitals and public health professionals in the United States that all healthy infants are at potential risk of kernicterus if their newborn jaundice is unmonitored and inadequately treated. The re-emergence of kernicterus in the United States is the result of interacting phenomena including (a) Early hospital discharge (before extent of jaundice is known and signs of impending brain damage have appeared); (b) Lack of adequate concern for the risks of severe jaundice in healthy term and near newborns; (c) An increase in breast feeding; (d) Medical care cost constraints; (e) Paucity of educational materials to enable parents to participate in safeguarding their newborns; and (f) Limitations within in healthcare systems to monitor the outpatient progression of jaundice. A multidisciplinary approach that encompasses both healthcare and societal needs should be evaluated at a national level for practical and easy to implement strategies. An approach that is based on principles of evidence-based medicine, patient-safety and family centeredness is presented in this article. These strategies should also be based on public awareness campaign such that the healthcare providers can attempt to achieve a "Zero Tolerance of Kernicterus" and thereby decrease both childhood disabilities and infant mortality within the community.

Entities:  

Mesh:

Year:  2003        PMID: 12841402     DOI: 10.1007/bf02723615

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  19 in total

1.  Neonatal jaundice and kernicterus.

Authors: 
Journal:  Pediatrics       Date:  2001-09       Impact factor: 7.124

2.  System-based approach to management of neonatal jaundice and prevention of kernicterus.

Authors:  Lois H Johnson; Vinod K Bhutani; Audrey K Brown
Journal:  J Pediatr       Date:  2002-04       Impact factor: 4.406

3.  Prediction of hyperbilirubinemia in near-term and term infants.

Authors:  D K Stevenson; A A Fanaroff; M J Maisels; B W Young; R J Wong; H J Vreman; J R MacMahon; C Y Yeung; D S Seidman; R Gale; W Oh; V K Bhutani; L H Johnson; M Kaplan; C Hammerman; H Nakamura
Journal:  Pediatrics       Date:  2001-07       Impact factor: 7.124

4.  A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns.

Authors:  A Kappas; G S Drummond; T Valaes
Journal:  Pediatrics       Date:  2001-07       Impact factor: 7.124

Review 5.  Hyperbilirubinemia in the term infant: when to worry, when to treat.

Authors:  L Johnson
Journal:  N Y State J Med       Date:  1991-11

6.  Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization.

Authors:  T B Newman; B Xiong; V M Gonzales; G J Escobar
Journal:  Arch Pediatr Adolesc Med       Date:  2000-11

7.  Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project.

Authors:  T B Newman; M A Klebanoff
Journal:  Pediatrics       Date:  1993-11       Impact factor: 7.124

Review 8.  Guidelines for management of the jaundiced term and near-term infant.

Authors:  L Johnson; V K Bhutani
Journal:  Clin Perinatol       Date:  1998-09       Impact factor: 3.430

9.  Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns.

Authors:  V K Bhutani; L Johnson; E M Sivieri
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

10.  Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin.

Authors:  J C Martinez; H O Garcia; L E Otheguy; G S Drummond; A Kappas
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

View more
  4 in total

1.  Prediction of significant hyperbilirubinemia in term neonates by early non-invasive bilirubin measurement.

Authors:  Manish Jain; Akash Bang; Anju Tiwari; Shuchi Jain
Journal:  World J Pediatr       Date:  2016-11-23       Impact factor: 2.764

2.  Family socio-demographic factors and maternal obstetric factors influencing appropriate health-care seeking behaviours for newborn jaundice in Sagamu, Nigeria.

Authors:  Tinuade A Ogunlesi; Funmilayo B Ogunlesi
Journal:  Matern Child Health J       Date:  2012-04

3.  Development of a mobile phone camera-based transcutaneous bilirubinometer for low-resource settings.

Authors:  Brandon Harrison-Smith; Alexander P Dumont; Mohammed Shahriar Arefin; Yu Sun; Nuradeen Lawal; Dorianna Dobson; Amy Nwaba; Sarah Grossarth; Abdulsalam Muhammed Paed; Zubaida L Farouk; Jorn-Hendrik Weitkamp; Chetan A Patil
Journal:  Biomed Opt Express       Date:  2022-04-15       Impact factor: 3.562

4.  Effect of clofibrate in jaundiced term newborns.

Authors:  Ashraf Mohammadzadeh; A Sh Farhat; R Iranpour
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.